{
  "id": "622dd1433a8413c6530000a5",
  "type": "yesno",
  "question": "Is taxilin a cancer marker?",
  "ideal_answer": "Yes,\n\u03b1-Taxilin, a binding partner of the syntaxin family, is a candidate tumor marker.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24091795",
    "http://www.ncbi.nlm.nih.gov/pubmed/32377534",
    "http://www.ncbi.nlm.nih.gov/pubmed/21042709",
    "http://www.ncbi.nlm.nih.gov/pubmed/28789367"
  ],
  "snippets": [
    {
      "text": "\u0391lpha-Taxilin (\u03b1-Taxilin) has been found as one of the novel, significantly up regulated protein in RA",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32377534",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Expression of \u03b1-taxilin has been implicated in the development of human glioblastoma, hepatocellular carcinoma and renal cell carcinoma. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28789367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "\u03b1-Taxilin, a binding partner of the syntaxin family, is a candidate tumor marker. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24091795",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Expression of \u03b1-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21042709",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}